Home LiteratureArticle Details
PMID: 11587047 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Follow-up of the WHO Multinational Study of Vascular Disease in Diabetes: general description and morbidity.

Diabetologia ·Vol. 44 Suppl 2 ·2001-09-00 ·Pages S3-13

Lee ET, Keen H, Bennett PH, Fuller JH, Lu M

Abstract

The incidence of retinal, renal and cardiovascular complications and their relation to baseline risk factors was documented in this follow-up study of 10 of the 14 original centres of the WHO Multinational Study of Vascular Disease in Diabetes (WHO MSVDD). The incidence of specified items of vascular disease and some associated risk factors was ascertained after 7 to 9 years (11-12 years in Oklahoma, USA) follow-up, re-using baseline examination methodology in 3165 patients (66.9 %) and, through secondary information in 717 (15.2%) of the 4729 original patients, of whom 540 (11.4%) had died and 307 (6.5 %) were untraceable. During follow-up, approximately one third of the patients developed hypertension and one third started insulin. Coronary heart disease incidence varied 10 to 20-fold among centres as did limb amputation rates. Inter-centre differences in incident retinopathy and severe visual impairment were smaller but incident clinical proteinuria and renal failure varied markedly. Vascular disease incidence of all categories was high in Native Americans though coronary heart disease incidence was relatively low in Pima Indians and absolutely low in Hong Kong and Tokyo patients. Specific vascular events and their relation with baseline risk factors are analysed in accompanying papers, summarised in the Epilogue. These 10 centres reported very different incidence rates of vascular complications. Observer variation, selection biases and competing causes of mortality contributed to these differences but their validity is supported by the more objective outcome indicators. The following papers also suggest that baseline factors such as raised arterial pressure, cholesterol and fasting glucose (in the centres where it was measured) were important and potentially reversible predictors of risk.

MeSH Terms
Adult Coronary Disease/epidemiology Diabetes Mellitus, Type 1/complications,epidemiology Diabetes Mellitus, Type 2/complications,epidemiology Diabetic Angiopathies/epidemiology Diabetic Nephropathies/epidemiology Diabetic Retinopathy/epidemiology Female Humans Hypertension/epidemiology Indians, North American International Cooperation Male Middle Aged Morbidity Proteinuria/epidemiology Risk Factors World Health Organization
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Lee E T
Centre for American Indian Health Research and Department of Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Centre, Oklahoma City 73190, USA.
Keen H
Bennett P H
Fuller J H
Lu M
Article Info
Journal
Diabetologia
Abbr.
Diabetologia
ISSN
0012-186X
Published
2001-09-00
Pages
S3-13
Language
English
Region
Germany
NLM ID
0006777
Subset
IM
Grants
NIDDK NIH HHS · N01-DK-8-2232 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com